Mogamulizumab Biosimilar – Research Grade: Biotin

Mogamulizumab Biosimilar – Research Grade

Biotin

CD194

n/a

Human IgG1κ

Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu

CHO Cells

Human

Detects human ErbB2. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Mogamulizumab . Our Mogamulizumab biosimilar is for research use only (RUO).

Mogamulizumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Mogamulizumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary).

0.5 mg/ml

This Biotin conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.

This Biotin conjugate is stable when stored at 2-8°C. Do not freeze.

Flow Cytometry, ELISA

Each investigator should determine their own optimal working dilution for specific applications.